Luseed Vascular appoints Aline Goldstein as QA / RA Director
Petach-Tikvah, ISRAEL, June 15th, 2023- LuSeed Vascular, the developer of an innovative solution for the treatment of brain aneurysms, has announced that Aline Goldstein has been nominated as QA / RA Director.
Aline present broad experience in Medical Device areas related to quality (establishment and maintenance of QMS, work closely with different functions to assure product quality and continue improvement, leading of QA activities in design project), compliance (implementation of regulatory requirements and support in regulatory audits) and regulations for global registration (support in regulatory submissions including preparation of submission files and communication with regulatory authorities in different territories
LuSeed Vascular Appoints Robert Stern to its Board of Directors
Petach-Tikvah, ISRAEL, January 17, 2023- LuSeed Vascular, the developer of an innovative solution for the treatment of brain aneurysms, has announced that Robert Stern, an experienced medical device executive and investor, has been nominated as Vice Chairman of the Board of Directors.
Mr. Stern currently serves as an advisor to several medical device companies and has been a board member of multiple neurovascular-focused companies, including Flexible Stenting Solutions, Reverse Medical, and Neuravi – all of which have been sold to strategic investors.